BANGALORE, India - Targeting rural India as the next big business opportunity seems to be the flavor of the season for multinational companies as GE Healthcare becomes the latest entity to realign its product strategy to primarily suit rural health centers
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
The company hopes the drug will become the standard of care rescue treatment in asthma.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
In this week's episode: Trump’s executive order more rhetoric than action; industry grapples with Trump pricing plan; Hengrui set for this year’s biggest IPO; Sanofi’s exec’s advice to biotechs; and biotech deal return on investment falls.
